Jonathan Violin

Insider Reports History

Entity
Individual
Location
955 Chesterbrook Boulevard, Suite 200, Chesterbrook, PA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Jonathan Violin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Violin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Common Stock 481K $10.1M $21.00 Feb 2, 2023 Direct
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Stock Option (Right to Buy) 239K Feb 2, 2023 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 14.1K Jun 5, 2024 Direct
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 11K May 23, 2024 Direct

Insider Reports Filed by Jonathan Violin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATXS Astria Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
DNTH Dianthus Therapeutics, Inc. /DE/ May 23, 2024 1 $0 4 May 28, 2024 Director
MGTA Dianthus Therapeutics, Inc. /DE/ Sep 11, 2023 1 $0 4 Sep 13, 2023 Director
MGTA Dianthus Therapeutics, Inc. /DE/ Sep 11, 2023 0 $0 3 Sep 13, 2023 Director
ATXS Astria Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Director
VRDN Viridian Therapeutics, Inc.\DE Feb 2, 2023 3 -$1.83M 4/A Feb 7, 2023 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Feb 2, 2023 1 -$1.84M 4 Feb 3, 2023 Chief Executive Officer, Director
ATXS Astria Therapeutics, Inc. Jun 9, 2022 1 $0 4/A Jun 21, 2022 Director
VRDN Viridian Therapeutics, Inc.\DE Jun 1, 2022 1 -$366K 4 Jun 2, 2022 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE May 2, 2022 1 -$391K 4 May 4, 2022 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Apr 1, 2022 2 -$568K 4 Apr 5, 2022 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Mar 1, 2022 2 -$529K 4 Mar 3, 2022 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Feb 1, 2022 4 -$573K 4 Feb 3, 2022 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Dec 8, 2021 2 $0 4 Dec 10, 2021 President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director
ATXS Astria Therapeutics, Inc. Sep 20, 2021 2 $0 4 Sep 22, 2021 Director
ATXS CATABASIS PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 2, 2021 Director